COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD

8/20 Early treatment study
Prodromos, C., New Microbes and New Infections, doi:10.1016/j.nmni.2020.100747 (Peer Reviewed) (not included in the study count)
Hydroxychloroquine is protective to the heart, not harmful: A systematic review
Source   PDF   Share   Tweet
Review concluding that HCQ/AZ does not cause Torsade de Pointes or related deaths, HCQ decreases cardiac events, and HCQ should not be restricted in use for COVID-19 patients because of fear of cardiac mortality.

Prodromos et al., 8/20/2020, peer-reviewed, 3 authors.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit